Although many patients with primary HSV-1 infection have no clinicalrecurrences, the failure to seroconvert occurs very seldom-inno more than 1% of patients.
Six weeks earlier, my patient had signs and symptoms of herpes simplex virus(HSV) infection, and results of a culture for HSV type 1 were positive. The patienthas had no recurrences, and recent blood tests for antibodies to HSV types 1 and 2are negative. How is this possible?
---- Diana Rodriguez, MD
Stoughton, MassAlthough many patients with primary HSV-1 infection have no clinicalrecurrences, the failure to seroconvert occurs very seldom--inno more than 1% of patients. Failure to seroconvert happens morefrequently following antiviral therapy of first-episode disease. Withtime--usually 6 months--seroconversion will occur.Because of the compatible clinical findings, I doubt that a laboratory erroroccurred in the initial evaluation; however, this possibility must be considered.It is also possible that the later serologic testing was flawed.Thus, I would repeat the serologic evaluation to make sure that there wasno laboratory error in the 6-week sample. This would be unusual, but it is possible.In the meantime, I would consider the patient infected.---- Richard Whitley, MD
Professor of Pediatrics, Microbiology, and Medicine
The University of Alabama School of Medicine
BirminghamEditor's note: Dr Rodriguez reported that a recent blood test for HSV antibodieswas positive.
Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD
June 11th 2025RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.